S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
S&P 500   3,768.25 (-0.72%)
DOW   30,814.26 (-0.57%)
QQQ   311.86 (-0.79%)
AAPL   127.14 (-1.37%)
MSFT   212.65 (-0.17%)
FB   251.36 (+2.33%)
GOOGL   1,727.62 (-0.19%)
AMZN   3,104.25 (-0.74%)
TSLA   826.16 (-2.23%)
NVDA   514.38 (-2.58%)
BABA   243.46 (+0.20%)
CGC   33.39 (-3.55%)
GE   11.33 (-2.83%)
MU   80.72 (-0.71%)
AMD   88.21 (-2.84%)
T   29.17 (-0.41%)
NIO   56.27 (-7.56%)
F   9.83 (-3.34%)
ACB   12.04 (+0.67%)
BA   204.32 (-2.66%)
DIS   171.44 (-1.15%)
NFLX   497.98 (-0.58%)
GILD   63.33 (+1.49%)
Log in
NYSE:QGEN

QIAGEN News Headlines

$53.20
+0.01 (+0.02 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$53.06
Now: $53.20
$53.69
50-Day Range
$47.25
MA: $51.27
$53.33
52-Week Range
$32.97
Now: $53.20
$55.27
Volume558,237 shs
Average Volume706,954 shs
Market Capitalization$12.12 billion
P/E Ratio1,773.33
Dividend YieldN/A
Beta0.31

Headlines

QIAGEN (NYSE QGEN) News Headlines Today

Source:
SourceHeadline
QIAGEN (NYSE:QGEN) Earns Sell Rating from DZ BankQIAGEN (NYSE:QGEN) Earns Sell Rating from DZ Bank
marketbeat.com - December 14 at 11:25 AM
QIAGEN (NYSE:QGEN) Lifted to "Buy" at Kepler Capital MarketsQIAGEN (NYSE:QGEN) Lifted to "Buy" at Kepler Capital Markets
marketbeat.com - November 26 at 10:17 PM
Qiagen (NYSE:QGEN) Downgraded to C+ at TheStreetQiagen (NYSE:QGEN) Downgraded to C+ at TheStreet
marketbeat.com - October 29 at 7:06 AM
Qiagen (NYSE:QGEN) Raised to "Hold" at Kepler Capital MarketsQiagen (NYSE:QGEN) Raised to "Hold" at Kepler Capital Markets
marketbeat.com - August 31 at 12:08 AM
Qiagen (NYSE:QGEN) Receives "Buy" Rating from JPMorgan Chase & Co.Qiagen (NYSE:QGEN) Receives "Buy" Rating from JPMorgan Chase & Co.
marketbeat.com - August 20 at 4:09 AM
Qiagen warns against using standard tests to track coronavirus variants - Yahoo FinanceQiagen warns against using standard tests to track coronavirus variants - Yahoo Finance
finance.yahoo.com - January 15 at 1:20 PM
Qiagen warns against using standard tests to track coronavirus variants - ReutersQiagen warns against using standard tests to track coronavirus variants - Reuters
reuters.com - January 15 at 1:55 AM
Qiagen warns against using standard tests to track coronavirus variantsQiagen warns against using standard tests to track coronavirus variants
finance.yahoo.com - January 14 at 8:55 PM
Testing Space in Focus Again Thanks to New Wave of CoronavirusTesting Space in Focus Again Thanks to New Wave of Coronavirus
finance.yahoo.com - January 13 at 12:30 PM
Global Bacterial and Plasmid Vectors Market Report 2020-2030 Featuring Sigma-Aldrich, ATUM, QIAGEN, Promega, Thermo Fisher Scientific, GenScript Biotech, Takara Bio, and New England Biolabs - PRNewswireGlobal Bacterial and Plasmid Vectors Market Report 2020-2030 Featuring Sigma-Aldrich, ATUM, QIAGEN, Promega, Thermo Fisher Scientific, GenScript Biotech, Takara Bio, and New England Biolabs - PRNewswire
prnewswire.com - January 13 at 7:29 AM
Form 6-K QIAGEN NV For: Jan 31 - StreetInsider.comForm 6-K QIAGEN NV For: Jan 31 - StreetInsider.com
streetinsider.com - January 9 at 9:47 AM
QIAGEN Announces Appointment of New Supervisory Board Member - Business WireQIAGEN Announces Appointment of New Supervisory Board Member - Business Wire
businesswire.com - January 8 at 11:11 PM
Qiagen (QGEN) Names Dr. Toralf Haag as Member of Supervisory Board - StreetInsider.comQiagen (QGEN) Names Dr. Toralf Haag as Member of Supervisory Board - StreetInsider.com
streetinsider.com - January 8 at 7:30 AM
QIAGEN Announces Appointment of New Supervisory Board Member - Yahoo FinanceQIAGEN Announces Appointment of New Supervisory Board Member - Yahoo Finance
finance.yahoo.com - January 8 at 7:30 AM
Traders Purchase High Volume of Call Options on QIAGEN (NYSE:QGEN)Traders Purchase High Volume of Call Options on QIAGEN (NYSE:QGEN)
americanbankingnews.com - January 7 at 12:46 PM
QIAGEN (NYSE:QGEN) Earns "Hold" Rating from Norddeutsche LandesbankQIAGEN (NYSE:QGEN) Earns "Hold" Rating from Norddeutsche Landesbank
americanbankingnews.com - January 6 at 10:42 AM
QIAGENs (QGEN) "Neutral" Rating Reiterated at Nord/LBQIAGEN's (QGEN) "Neutral" Rating Reiterated at Nord/LB
americanbankingnews.com - January 6 at 10:01 AM
QIAGEN (NYSE:QGEN) Given Consensus Recommendation of "Hold" by BrokeragesQIAGEN (NYSE:QGEN) Given Consensus Recommendation of "Hold" by Brokerages
americanbankingnews.com - January 3 at 1:22 AM
Heres Why You Should Hold on to QIAGEN (QGEN) Stock for Now - Yahoo FinanceHere's Why You Should Hold on to QIAGEN (QGEN) Stock for Now - Yahoo Finance
finance.yahoo.com - December 21 at 10:41 AM
Bruker (BRKR) Launches PCR Panel, Expands Testing PortfolioBruker (BRKR) Launches PCR Panel, Expands Testing Portfolio
finance.yahoo.com - December 21 at 10:41 AM
Insights on the Legionella Testing Global Market to 2027 - Featuring bioMerieux, Qiagen and Thermo Fisher Scientific Among Others - Yahoo Finance UKInsights on the Legionella Testing Global Market to 2027 - Featuring bioMerieux, Qiagen and Thermo Fisher Scientific Among Others - Yahoo Finance UK
uk.finance.yahoo.com - December 18 at 7:41 AM
QIAGEN Underlines and Innovates Its Commitment to Sustainability With a EUR 400mn Sustainability-linked Credit Facility - Business WireQIAGEN Underlines and Innovates Its Commitment to Sustainability With a EUR 400mn Sustainability-linked Credit Facility - Business Wire
businesswire.com - December 18 at 7:41 AM
QIAGEN Underlines and Innovates Its Commitment to Sustainability With a EUR 400mn Sustainability-linked Credit Facility - Yahoo FinanceQIAGEN Underlines and Innovates Its Commitment to Sustainability With a EUR 400mn Sustainability-linked Credit Facility - Yahoo Finance
finance.yahoo.com - December 17 at 8:14 PM
QIAGEN Underlines and Innovates Its Commitment to Sustainability With a EUR 400mn Sustainability-linked Credit FacilityQIAGEN Underlines and Innovates Its Commitment to Sustainability With a EUR 400mn Sustainability-linked Credit Facility
finance.yahoo.com - December 17 at 8:14 PM
Statement from Davidson Kempner regarding Qiagen - PRNewswireStatement from Davidson Kempner regarding Qiagen - PRNewswire
prnewswire.com - December 16 at 3:49 AM
Qiagen Shares Move Higher Over Last 15 Minutes; Ellume COVID-19 Home Is First Over-The-Counter COVID-19 Test To Get FDA Authorization - BenzingaQiagen Shares Move Higher Over Last 15 Minutes; Ellume COVID-19 Home Is First Over-The-Counter COVID-19 Test To Get FDA Authorization - Benzinga
benzinga.com - December 15 at 5:48 PM
Statement from Davidson Kempner regarding Qiagen - Yahoo FinanceStatement from Davidson Kempner regarding Qiagen - Yahoo Finance
finance.yahoo.com - December 15 at 7:43 AM
QIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible Bonds and Price to Non-US Holders to Sell Outstanding Convertible Notes Due 2021 - Business WireQIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible Bonds and Price to Non-US Holders to Sell Outstanding Convertible Notes Due 2021 - Business Wire
businesswire.com - December 11 at 9:32 PM
QIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible Bonds and Price to Non-US Holders to Sell Outstanding Convertible Notes Due 2021QIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible Bonds and Price to Non-US Holders to Sell Outstanding Convertible Notes Due 2021
finance.yahoo.com - December 11 at 9:32 PM
Qiagen will expand its Germantown manufacturing facility, pursue new space as it ramps up Covid testing - Washington Business JournalQiagen will expand its Germantown manufacturing facility, pursue new space as it ramps up Covid testing - Washington Business Journal
bizjournals.com - December 11 at 4:31 PM
Qiagen Reaches Analyst Target Price - NasdaqQiagen Reaches Analyst Target Price - Nasdaq
nasdaq.com - December 11 at 11:31 AM
Form 6-K QIAGEN NV For: Dec 31 - StreetInsider.comForm 6-K QIAGEN NV For: Dec 31 - StreetInsider.com
streetinsider.com - December 10 at 11:43 PM
QIAGEN N.V.: QIAGEN N.V. launches non-U.S. offering of net share settled convertible bonds and solicits offers from non-U.S. holders to sell any and all of the outstanding convertible notes due 2021 - Yahoo Finance UKQIAGEN N.V.: QIAGEN N.V. launches non-U.S. offering of net share settled convertible bonds and solicits offers from non-U.S. holders to sell any and all of the outstanding convertible notes due 2021 - Yahoo Finance UK
uk.finance.yahoo.com - December 10 at 6:41 AM
Germanys Qiagen sees solid growth in 2020, 2021 and post-pandemic - Yahoo Finance UKGermany's Qiagen sees solid growth in 2020, 2021 and post-pandemic - Yahoo Finance UK
uk.finance.yahoo.com - December 8 at 10:12 PM
Breakingviews - Corona Capital: Testing boom, Japan stimulus, EQT - ReutersBreakingviews - Corona Capital: Testing boom, Japan stimulus, EQT - Reuters
reuters.com - December 8 at 8:28 AM
Qiagen ups profit and sales outlook - MarketWatchQiagen ups profit and sales outlook - MarketWatch
marketwatch.com - December 8 at 8:28 AM
QIAGEN Increases Outlook for 2020 and 2021 - Business WireQIAGEN Increases Outlook for 2020 and 2021 - Business Wire
businesswire.com - December 8 at 8:28 AM
Qiagen Lifts Q4, FY Outlook; To Expand Supervisory Board - NasdaqQiagen Lifts Q4, FY Outlook; To Expand Supervisory Board - Nasdaq
nasdaq.com - December 8 at 3:27 AM
Germanys Qiagen raises its targets for 2020 and 2021 - NasdaqGermany's Qiagen raises its targets for 2020 and 2021 - Nasdaq
nasdaq.com - December 8 at 3:27 AM
QIAGEN Increases Outlook for 2020 and 2021 - Yahoo FinanceQIAGEN Increases Outlook for 2020 and 2021 - Yahoo Finance
finance.yahoo.com - December 8 at 3:27 AM
QIAGEN Increases Outlook for 2020 and 2021QIAGEN Increases Outlook for 2020 and 2021
finance.yahoo.com - December 8 at 3:27 AM
QIAGEN to Launch QuantiFERON SARS-CoV-2 For Research Into Causes, Spread and Control of COVID-19 Through T-cell Response - Business WireQIAGEN to Launch QuantiFERON SARS-CoV-2 For Research Into Causes, Spread and Control of COVID-19 Through T-cell Response - Business Wire
businesswire.com - December 7 at 2:21 AM
QIAGEN to Launch QuantiFERON SARS-CoV-2 For Research Into Causes, Spread and Control of COVID-19 Through T-cell ResponseQIAGEN to Launch QuantiFERON SARS-CoV-2 For Research Into Causes, Spread and Control of COVID-19 Through T-cell Response
finance.yahoo.com - December 7 at 2:20 AM
Qiagen, N.V. And Medical Diagnostics Competitors - Seeking AlphaQiagen, N.V. And Medical Diagnostics Competitors - Seeking Alpha
seekingalpha.com - December 3 at 3:03 AM
Is QIAGEN (QGEN) a Profitable Stock to Pick Right Now ? - NasdaqIs QIAGEN (QGEN) a Profitable Stock to Pick Right Now ? - Nasdaq
nasdaq.com - November 25 at 12:45 PM
Is QIAGEN (QGEN) a Profitable Stock to Pick Right Now ?Is QIAGEN (QGEN) a Profitable Stock to Pick Right Now ?
finance.yahoo.com - November 25 at 12:45 PM
Qiagen: Strong Short-Term COVID Play - Seeking AlphaQiagen: Strong Short-Term COVID Play - Seeking Alpha
seekingalpha.com - November 23 at 3:08 PM
John Paulson Buys Lear, Sells TD AmeritradeJohn Paulson Buys Lear, Sells TD Ameritrade
finance.yahoo.com - November 23 at 3:08 PM
QIAGEN (QGEN), BioNTech to Develop Test to Identify SCCHN - Yahoo FinanceQIAGEN (QGEN), BioNTech to Develop Test to Identify SCCHN - Yahoo Finance
finance.yahoo.com - November 19 at 5:44 PM
QIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck - Business WireQIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck - Business Wire
businesswire.com - November 19 at 1:17 AM
QIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and NeckQIAGEN Collaborates with BioNTech on Companion Diagnostics Development for HPV-associated Squamous Cell Carcinoma of the Head and Neck
businesswire.com - November 18 at 4:08 PM
QIAGEN (QGEN) Launches PCR Test, Expands Testing Portfolio - Yahoo FinanceQIAGEN (QGEN) Launches PCR Test, Expands Testing Portfolio - Yahoo Finance
finance.yahoo.com - November 17 at 11:45 PM
Heres Why You Should Hold on to QIAGEN (QGEN) Stock for Now - NasdaqHere's Why You Should Hold on to QIAGEN (QGEN) Stock for Now - Nasdaq
nasdaq.com - November 17 at 1:28 PM
QIAGEN (QGEN) Launches COVID-19 Antigen Test With Ellume - NasdaqQIAGEN (QGEN) Launches COVID-19 Antigen Test With Ellume - Nasdaq
nasdaq.com - November 17 at 3:27 AM
QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets - Yahoo FinanceQIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets - Yahoo Finance
finance.yahoo.com - November 16 at 5:26 PM
This page was last updated on 1/15/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.